Revenue from Contracts with Customers (Tables)

3 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenue by Reporting Unit

	Three months ended December 31,
	2021		2020
Significant Business Line
Life Sciences Products	$	49,877	$	45,508
Sample Repository Solutions		25,871		20,533
Genomic Services		63,904		52,101
Total	$	139,652	$	118,142

Remaining Performance Obligations

	As of December 31, 2021
	Less than 1 Year		Greater than 1 Year		Total
Remaining Performance Obligations	$	37,409	$	15,971	$	53,380